Comments

Fennec Pharmaceuticals Stock Guidance

FENCNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
Fennec Pharmaceuticals (FENC) ForecastNewsEarningsFennec Pharmaceuticals (FENC) Options

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

Fennec Pharmaceuticals Stock Guidance | NASDAQ:FENC | Benzinga

Fennec Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
02/29/2024FENC
Fennec Pharmaceuticals
Q42023———$9.20M$9.70M$8.06MGet Alert
02/29/2024FENC
Fennec Pharmaceuticals
FY2023———$20.70M$21.20M$19.57MGet Alert

FAQ

Q

What is the most recent guidance for Fennec Pharmaceuticals (FENC)?

A

There have been no specific sales or earnings guidance reported for Fennec Pharmaceuticals in recent months.

Browse guidance and forecast on all stocks.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved